申请人:Mitsubishi Chemical Corporation
公开号:EP0623627A1
公开(公告)日:1994-11-09
Since sulfonamide derivatives of the present invention show strong inhibitory activity against cysteine protease such as calpain papain, cathepsin B, cathepsin H, cathepsin L, they can be used as remedies for muscular dystrophy, cataract, myocardial infarction, stroke, Alzheimer's disease, amyotrophia, osteoporosis, hypercalcemia or the like.
由于本发明的磺酰胺衍生物对半胱氨酸蛋白酶(如钙蛋白酶木瓜蛋白酶、酪蛋白酶 B、酪蛋白酶 H、酪蛋白酶 L)具有很强的抑制活性,因此可用作治疗肌肉萎缩症、白内障、心肌梗塞、中风、老年痴呆症、肌萎缩症、骨质疏松症、高钙血症或类似疾病的药物。